New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2020, WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: Module 1: prevention
View latest version (2020)Bibliographic information
GuidelineGuidelines on the management of latent tuberculosis infection
Year of Publication2014
Issuing InstitutionWHO
Recommendation
Retired
The following treatment options are recommended for the treatment of latent tuberculosis infection (LTBI): 6-month isoniazid, or 9-month isoniazid, or 3-month regimen of weekly rifapentine plus isoniazid, or 3–4 months isoniazid plus rifampicin, or 3–4 months rifampicin alone
Recommended in favor
Strong
Certainty of evidence
Moderate